Why is Remedium Life falling/rising?

As of 02-Jul, Remedium Lifecare Ltd's stock price is currently at 1.06, reflecting an increase of 0.04 or 3.92%. The stock has shown a strong performance recently, gaining 26.19% over the last six days and outperforming its sector by 3.15% today. However, despite this short-term rise, the stock has experienced significant declines over longer periods, with a 1-month return of -35.76% and a staggering -92.24% over the past year. The company faces challenges, including a high Debt to EBITDA ratio of -1.00 times and a history of negative results, which contribute to its classification as a strong sell. The stock's liquidity appears adequate for trading, but delivery volume has decreased significantly, indicating falling investor participation.
In the broader market context, while Remedium Lifecare Ltd has outperformed the Sensex by a notable margin in the short term, the overall performance remains concerning when viewed against longer-term benchmarks. The Sensex has shown a modest increase of 2.50% over the past month and 6.75% year-to-date, contrasting sharply with the company's poor performance. This disparity highlights the stock's volatility and the risks associated with its financial health, as it has consistently underperformed against broader market indices over various time frames.